Free Trial

Bank of New York Mellon Corp Trims Position in Select Medical Holdings Co. (NYSE:SEM)

Select Medical logo with Medical background
Remove Ads

Bank of New York Mellon Corp reduced its stake in Select Medical Holdings Co. (NYSE:SEM - Free Report) by 7.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,384,560 shares of the health services provider's stock after selling 110,238 shares during the quarter. Bank of New York Mellon Corp owned approximately 1.07% of Select Medical worth $26,099,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of SEM. Quarry LP bought a new position in shares of Select Medical during the third quarter valued at about $30,000. Wilmington Savings Fund Society FSB purchased a new stake in shares of Select Medical during the third quarter valued at approximately $81,000. Virtu Financial LLC bought a new stake in Select Medical during the third quarter worth $210,000. Quantbot Technologies LP purchased a new position in Select Medical in the third quarter worth $232,000. Finally, Tidal Investments LLC bought a new position in Select Medical in the 3rd quarter valued at $286,000. 89.48% of the stock is currently owned by institutional investors.

Select Medical Stock Performance

Select Medical stock traded down $0.24 during mid-day trading on Thursday, reaching $16.56. The company's stock had a trading volume of 544,148 shares, compared to its average volume of 740,744. The company has a market capitalization of $2.13 billion, a P/E ratio of 10.03, a PEG ratio of 0.64 and a beta of 1.56. Select Medical Holdings Co. has a 12-month low of $16.20 and a 12-month high of $40.98. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The firm's fifty day moving average price is $18.84 and its two-hundred day moving average price is $26.55.

Remove Ads

Select Medical (NYSE:SEM - Get Free Report) last posted its earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.29 by ($0.11). The firm had revenue of $1.31 billion during the quarter, compared to analysts' expectations of $1.50 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. Sell-side analysts predict that Select Medical Holdings Co. will post 1.17 EPS for the current fiscal year.

Select Medical Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 13th. Investors of record on Monday, March 3rd will be given a $0.0625 dividend. This represents a $0.25 annualized dividend and a dividend yield of 1.51%. The ex-dividend date of this dividend is Monday, March 3rd. Select Medical's dividend payout ratio (DPR) is 15.15%.

Analysts Set New Price Targets

SEM has been the subject of a number of research analyst reports. Benchmark upgraded shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price objective for the company in a report on Monday, February 24th. UBS Group lowered their price target on shares of Select Medical from $40.00 to $21.00 and set a "neutral" rating on the stock in a report on Friday, January 3rd. Royal Bank of Canada reduced their price objective on Select Medical from $47.00 to $23.00 and set an "outperform" rating for the company in a report on Monday, February 24th. Finally, StockNews.com upgraded Select Medical from a "hold" rating to a "buy" rating in a research note on Friday, February 21st. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat, Select Medical has an average rating of "Moderate Buy" and an average price target of $27.25.

Get Our Latest Stock Analysis on Select Medical

Select Medical Profile

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Further Reading

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Should You Invest $1,000 in Select Medical Right Now?

Before you consider Select Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.

While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads